Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2020 | 2019 | 2017 | 2016 | 2015 | 2014
Number of items: 9.

2020

Livingstone, E., Zaremba, A., Horn, S., Ugurel, S., Casalini, B., Schlaak, M., Hassel, J. C., Herbst, R., Utikal, J. S., Weide, B., Gutzmer, R., Meier, F., Koelsche, C., Hadaschik, E., Sucker, A., Reis, H., Merkelbach-Bruse, S., Siewert, M., Sahm, F., von Deimling, A., Cosgarea, I., Zimmer, L., Schadendorf, D., Schilling, B. and Griewank, K. G. (2020). GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. Br. J. Dermatol., 183 (5). S. 928 - 940. HOBOKEN: WILEY. ISSN 1365-2133

Zaremba, A., Martaki, A., Salzmann, M., Baroudjian, B., Sachse, M. M., Gesierich, A., Reinhardt, L., Meier, F., Hassel, J. C., Ugurel, S., Roesch, A., Schadendorf, D., Livingstone, E., Broeckelmann, P., Kramer, R., Heinzerling, L. and Zimmer, L. (2020). Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation. J. Dtsch. Dermatol. Ges., 18. S. 15 - 17. HOBOKEN: WILEY. ISSN 1610-0387

2019

Surowy, H. M., Giesen, A. K., Otte, J., Buettner, R., Falkenstein, D., Friedl, H., Meier, F., Petzsch, P., Wachtmeister, T., Westphal, D., Wieczorek, D., Wruck, W., Adjaye, J., Ruetten, A. and Redler, S. (2019). Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma. Br. J. Dermatol., 180 (5). S. 1150 - 1161. HOBOKEN: WILEY. ISSN 1365-2133

2017

Heppt, M. V., Schlaak, M., Eigentler, T. K., Kaehler, K. C., Kiecker, F., Loquai, C., Meier, F., Tomsitz, D., Brenner, N., Niesert, A. C., Thonke, R., Hauschild, A. and Berking, C. (2017). Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients. Ann. Oncol., 28 (12). S. 3104 - 3108. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

2016

Hunzelmann, N., Riemekasten, G., Becker, M. O., Moinzadeh, P., Kreuter, A., Melchers, I., Mueller-Ladner, U., Meier, F., Worm, M., Lee, H., Herrgott, I., Pfeiffer, C., Fierlbeck, G., Henes, J., Juche, A., Zeidler, G., Mensing, H., Guenther, C., Sardy, M., Burkhardt, H., Koehm, M., Kuhr, K., Krieg, T. and Sunderkoetter, C. (2016). The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. Br. J. Dermatol., 174 (6). S. 1384 - 1388. HOBOKEN: WILEY. ISSN 1365-2133

2015

Hunzelmann, N., Moinzadeh, P., Riemekasten, G., Becker, M., Kreuter, A., Mueller-Ladner, U., Meier, F., Wozel, G., Melchers, I., Srdy, M., Sunderkoetter, C., Herrgott, I., Graefenstein, K., Zeidler, G., Fierlbeck, G., Pfeiffer, C., Worm, M., Lee, H., Burkhardt, H., Koehm, M., Henes, J., Mensing, H., Kuhr, K. and Krieg, T. (2015). Low risk for digital ulcer development in SSc patients with increasing disease duration and lack of Scl-70 autoantibodies. Exp. Dermatol., 24 (3). S. E11 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625

Hunzelmann, N., Moinzadeh, P., Riemekasten, G., Becker, M., Kreuter, A., Mueller-Ladner, U., Meier, F., Wozel, G., Melchers, I., Srdy, M., Sunderkoetter, C., Herrgott, I., Graefenstein, K., Zeidler, G., Fierlbeck, G., Pfeiffer, C., Worm, M., Lee, H., Burkhardt, H., Koehm, M., Henes, J., Mensing, H., Kuhr, K. and Krieg, T. (2015). Low risk for digital ulcer development in SSc patients with increasing disease duration and lack of Scl-70 autoantibodies. Exp. Dermatol., 24 (3). S. E11 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625

2014

Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J. H. W., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Kuhr, K., Lorenz, H. -M., Meier, F., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Schmalzing, M., Sunderkoetter, C., Susok, L., Tarner, I. H., Vaith, P., Worm, M., Wozel, G., Zeidler, G. and Hunzelmann, N. (2014). SSC-OVERLAP SYNDROMES: A DISTINCT CLINICAL SUBGROUP WITH SIGNIFICANT DIFFERENCES IN DISEASE PROGRESSION COMPARED TO LSSC AND DSSC PATIENTS. Clin. Exp. Rheumatol., 32 (2). S. S119 - 2. PISA: CLINICAL & EXPER RHEUMATOLOGY. ISSN 1593-098X

Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J. W., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Kuhr, K., Lorenz, H. M., Meier, F., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Schmalzing, M., Sunderkoetter, C., Susok, L., Tarner, I. H., Vaith, P., Worm, M., Zeidler, G. and Hunzelmann, N. (2014). SSc-overlap syndromes: a distinct clinical subgroup with significant differences in disease progression compared to lSSc and dSSc patients. Data of the German Network for Systemic Scleroderma (DNSS). Exp. Dermatol., 23 (3). S. E13 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625

This list was generated on Thu May 2 02:09:43 2024 CEST.